AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

GOLIMUMAB

10 registrations across 5 African markets— 8 active

Markets with GOLIMUMAB

Recent registrations

Brand / ProductMarketHolderStatusExpires
Simponi 50mg Pre filled Syringe
Solution For Infusion In Pre-Filled Syringe
🇰🇪KenyaJanssen Biologics B.VactiveJul 2031
SIMPONI 50mg/0.5ml SOLUTION FOR INJECTION IN A PRE-FILLED SYRINGE (GOLIMUMAB)🇬🇭GhanaactiveFeb 2029
SIMPONI 100mg/0.5ml SOLUTION FOR INJECTION IN A PRE-FILLED SYRINGE (GOLIMUMAB)🇬🇭GhanaactiveFeb 2029
SIMPONI 100mg/0.5ml SOLUTION FOR INJECTION IN A PRE-FILLED SYRINGE (GOLIMUMAB)🇬🇭GhanaactiveFeb 2029
SIMPONI 50mg/0.5ml SOLUTION FOR INJECTION IN A PRE-FILLED SYRINGE (GOLIMUMAB)🇬🇭GhanaactiveFeb 2029
SIMPONI
Solution injectable / 50 MG
🇹🇳TunisiaJANSSEN BIOLOGICS B.VexpiredMay 2017
SIMPONI
Solution injectable / 50 MG
🇹🇳TunisiaJANSSEN BIOLOGICS B.VexpiredMay 2017
SIMPONI🇿🇦South AfricaJanssen Pharmaceutica (Pty) LtdactiveJan 1900
Simponi 100 mg solution for injection PFP
Solution for injection
🇳🇬Nigeriaactive
Simponi Solution for Injection in Prefilled Pen
Solution for injection
🇳🇬Nigeriaactive

GOLIMUMAB in Africa — Regulatory Overview

GOLIMUMAB is registered across 5 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Nigeria, Tunisia, Kenya and 1 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 8 (80%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.